CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Placebo-controlled, Double Blind Trial of Semaglutide 1mg (Ozempic®) on Regression to Normoglycemia in WomEn with a Recent History of Gestational DiabETes Mellitus: the SWEET Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04873050
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:44.834299+00:00
Published At: 2025-03-13T00:00:00+00:00
Record Updated At: 2025-03-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Pre Diabetes", "Postpartum Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-13"
protocolSection.identificationModule.nctId: "NCT04873050"
protocolSection.identificationModule.officialTitle: "A Randomized, Placebo-controlled, Double Blind Trial of Semaglutide 1mg (Ozempic\u00ae) on Regression to Normoglycemia in WomEn with a Recent History of Gestational DiabETes Mellitus: the SWEET Study"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.